According to our (Global Info Research) latest study, the global Hyperthermic Perfusion System market size was valued at US$ 46.46 million in 2025 and is forecast to a readjusted size of US$ 64.33 million by 2032 with a CAGR of 4.7% during review period.
A Hyperthermic Perfusion System, also known as hyperthermic chemotherapy delivery system, is a medical device designed to administer chemotherapy drugs at an elevated temperature directly to a specific area of the body. This treatment approach is used in various medical contexts, including hyperthermic intraperitoneal chemotherapy (HIPEC) and hyperthermic limb perfusion (HILP), to enhance the effectiveness of chemotherapy in treating cancer. Temperature Control Unit is responsible for heating and maintaining the chemotherapy solution at a precise and elevated temperature. In HIPEC, for example, the temperature is typically maintained in the range of 41-43 degrees Celsius (105-109 degrees Fahrenheit). The controlled hyperthermia is an essential aspect of the treatment's effectiveness. Hyperthermic Perfusion Systems are used in highly specialized medical procedures and are typically operated by trained medical professionals, including surgeons and anesthesia providers. The price of the main unit for Hyperthermic Perfusion System typically ranges from approximately US$70,000 to US$150,000 per unit.
The upstream supply chain for Hyperthermic Perfusion System mainly includes medical-grade pumps, heat exchangers, temperature sensors, pressure monitoring components, control systems, tubing sets, reservoirs, filters, sterile disposable kits, and biocompatible materials that meet medical device standards. Key manufacturing capabilities are concentrated in fluid temperature control, stable perfusion flow, real-time monitoring, sterility assurance, and system safety design. Downstream demand mainly comes from hospitals, cancer centers, surgical oncology departments, and specialized HIPEC treatment centers, where the equipment is used during cytoreductive surgery to circulate heated chemotherapy solution within the abdominal cavity. Market demand is closely linked to the clinical adoption of HIPEC procedures, hospital investment in oncology surgery capabilities, availability of trained surgical teams, and the recurring use of disposable procedure kits for each treatment.
This report is a detailed and comprehensive analysis for global Hyperthermic Perfusion System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hyperthermic Perfusion System market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Hyperthermic Perfusion System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Hyperthermic Perfusion System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Hyperthermic Perfusion System market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hyperthermic Perfusion System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hyperthermic Perfusion System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ThermaSolutions, Gamida Tech, RanD Biotech, Belmont Medical Technologies, Combat Medical, Medica, Morestep Medical, Guangzhou BRM, Shenzhen Cooper Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hyperthermic Perfusion System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Integrated HIPEC Systems
Modular HIPEC Systems
Market segment by Perfusion Method
Open HIPEC System
Closed HIPEC System
Hybrid HIPEC System
Market segment by Application
Colorectal Cancer
Ovarian Cancer
Gastric Cancer
Others
Major players covered
ThermaSolutions
Gamida Tech
RanD Biotech
Belmont Medical Technologies
Combat Medical
Medica
Morestep Medical
Guangzhou BRM
Shenzhen Cooper Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hyperthermic Perfusion System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hyperthermic Perfusion System, with price, sales quantity, revenue, and global market share of Hyperthermic Perfusion System from 2021 to 2026.
Chapter 3, the Hyperthermic Perfusion System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyperthermic Perfusion System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hyperthermic Perfusion System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hyperthermic Perfusion System.
Chapter 14 and 15, to describe Hyperthermic Perfusion System sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Hyperthermic Perfusion System. Industry analysis & Market Report on Hyperthermic Perfusion System is a syndicated market report, published as Global Hyperthermic Perfusion System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Hyperthermic Perfusion System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.